Original Source(s)
Related Content
Stockholm3 Detected More Significant Prostate Cancers Than PSA
In a Swedish population-based screening cohort, the blood-based risk model had higher short-term sensitivity for clinically significant prostate cancer than prostate-specific antigen testing, with similar specificity.
June 25, 2026
-
5 min
Can Belzutifan Improve Adjuvant Therapy?
The phase 3 LITESPARK-022 trial compared adjuvant pembrolizumab plus belzutifan with pembrolizumab plus placebo following resection of clear-cell renal-cell carcinoma.
July 8, 2026
-
4 min
Benchmark for Functional Vision Loss Uncovered in Older Adults
A nationally representative US cohort identified a contrast sensitivity threshold associated with self-reported visual disability.
July 7, 2026
-
3 min